Ignite Creation Date:
2024-05-05 @ 11:11 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01275222
Status:
COMPLETED
Last Update Posted:
2021-06-25
First Post:
2011-01-10
Brief Title:
Everolimus in Combination With Imatinib in Patients With Glivec RefractoryResistant Gastrointestinal Stromal Tumors
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-11-13
Start Date Type:
ACTUAL
Primary Completion Date:
2008-09-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-09-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-01-10
First Submit QC Date:
January 11 2011
Study First Post Date:
2011-01-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-06-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-03
Last Update Post Date:
2021-06-25
Last Update Post Date Type:
ACTUAL